AbstractObjectiveThe underlying mechanisms of therapeutic hypothermia, which protects neurons after severe brain damage, are partially understood. T cells infiltrate the brain within days after cerebral ischemia and play essential roles in exacerbating the delayed phase of brain injury by producing cytotoxic factors, which were also systematically shown to be involved in brain damage. Periphery brain abnormalities are interesting, because the periphery might constitute a pathway to the central nervous system and therefore could also be a target of therapeutic hypothermia. We elucidated the effects of hypothermia and hyperthermia on peripheral T cell‐derived perforin (Pfn), and the underlying mechanism of Pfn‐mediated neurotoxicity and death of brain microvascular endothelial cells (BMVECs).MethodsWe determined the levels of Pfn produced by activated CD4+ and CD8+ T cells obtained from healthy humans under hypothermic, normothermic and hyperthermic conditions. The viability in response to Pfn treatment was assessed in neuronal Neuro‐2a and brain microvascular endothelial bEnd.3 cells.ResultsCompared with normothermia, Pfn release in both CD4+ and CD8+ T cells was reduced by hypothermia, but augmented by hyperthermia. Pfn caused the death of Neuro‐2a cells, and induced both apoptosis and necrosis in bEnd.3 cells; both effects were concentration‐dependent.ConclusionsHypothermia reduces T cell‐derived release of Pfn, which mediates neuronal cell death and apoptosis/necrosis of BMVECs, suggesting that therapeutic hypothermia elicits protection in the neurons and BMVECs in the delayed phase of brain injury by directly reducing the release of T cell‐derived Pfn. BMVECs protection can aid in reduced vascular permeability and blood–brain barrier protection.
Read full abstract